You just read:

Encapsulife Receives U.S. Patent Office Notice of Allowance For Living-Cell Bio-artificial Pancreas Requiring No Immune-Suppression -- Constitutes Dramatic Milestone Toward Curing Diabetes

News provided by

Encapsulife, Inc.

Feb 19, 2014, 11:10 ET